Advertisement

June 8, 2020

Shockwave Medical Announces New CMS Codes for Reimbursement of Intravascular Lithotripsy Procedures

June 8, 2020—Shockwave Medical, Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has issued new codes for intravascular lithotripsy (IVL) procedures performed in peripheral arteries in the hospital outpatient and inpatient settings to treat complex calcified cardiovascular disease.

The company advised that under these new codes, Medicare payment rates for IVL procedures performed in the hospital outpatient and inpatient settings, respectively, are consistent with current payment levels for other similar peripheral artery interventional procedures.

The new Healthcare Common Procedure Coding System outpatient and International Classification of Diseases, Tenth Revision, Procedure Coding System inpatient codes will go into effect on July 1, 2020, and October 1, 2020, respectively. A complete listing of Shockwave IVL reimbursement codes is provided on the company’s website.

“The decision by CMS to assign codes for peripheral IVL procedures in both outpatient and inpatient settings is an important validation of Shockwave’s technology as a unique and distinct therapy for treating complex calcified disease in the peripheral arteries,” commented Shockwave Medical’s President and CEO Doug Godshall in the announcement. “We look forward to continued engagement with CMS as these new codes will now enable the collection of cost data specific to IVL procedures, which is the information the agency utilizes when making future adjustments to procedure payment levels. The appreciation for IVL’s unique ability to safely and effectively treat these challenging patients is growing globally, and we are grateful that CMS has taken this important first step on the path toward establishing a reimbursement level that appropriately reflects the clinical value delivered by IVL.”

Advertisement


June 8, 2020

Surmodics SurVeil DCB Receives CE Mark Approval

June 8, 2020

Cook Medical Launches Transluminal Biliary Biopsy Forceps Set and Zilver 635 Biliary Stent in the United States